Get the Stockscreener App
1.27
1.60%
0.02
Evogene Ltd stock is traded at $1.27, with a volume of 3,843.
It is up +1.60% in the last 24 hours and down -13.01% over the past month.
See More
Previous Close:
$1.25
Open:
$1.25
24h Volume:
3,843
Relative Volume:
0.13
Market Cap:
$8.49M
Revenue:
$5.64M
Net Income/Loss:
$-23.88M
P/E Ratio:
-2.3962
EPS:
-0.53
Net Cash Flow:
$-22.36M
1W Performance:
-3.79%
1M Performance:
-13.01%
6M Performance:
-56.21%
1Y Performance:
-83.22%
1-Day Range:
$1.22
$1.30
1-Week Range:
$1.22
$1.38
52-Week Range:
$1.20
$8.996
Evogene Ltd Stock (EVGN) Company Profile
Compare EVGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.27 | 8.49M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-21 | Initiated | ROTH Capital | Buy |
| Jul-29-21 | Initiated | Aegis Capital | Buy |
| Dec-01-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-16-13 | Initiated | Oppenheimer | Outperform |
Evogene Ltd Stock (EVGN) Latest News
Evogene (NASDAQ:EVGN) Coverage Initiated at StockNews.com - Defense World
Evogene (NASDAQ:EVGN) Share Price Passes Below 200 Day Moving Average – What’s Next? - Defense World
StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split - Marketscreener.com
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene Announces Filing of Annual Report on Form 20-F - GuruFocus.com
AgPlenus Announces Discovery of a New Mode of Action for Fungici - GuruFocus.com
Evogene Ltd. Earnings Call: Growth Amid Challenges - TipRanks
Evogene Ltd. (NASDAQ:EVGN) Q4 2024 Earnings Call Transcript - Insider Monkey
Evogene price target lowered to $6 from $11.25 at Alliance Global Partners - TipRanks
Evogene: Q4 Earnings Snapshot - Barchart
Evogene Ltd to Host Earnings Call - ACCESS Newswire
Evogene Ltd. (NASDAQ:EVGN) Short Interest Up 22.1% in February - Defense World
Evogene Ltd (EVGN) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 - StreetInsider.com
Evogene Ltd. Reports Revenue Growth and Strategic Focus - TipRanks
Evogene Reports Fourth Quarter and Full Year 2024 Financial Results - The Malaysian Reserve
Earnings call transcript: Evogene Q4 2024 beats EPS forecast, misses revenue - Investing.com
Evogene Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Evogene reports Q4 EPS 6c vs. ($1.30) last year - TipRanks
Evogene reports Q4 revenue miss, shares slip By Investing.com - Investing.com South Africa
Evogene reports Q4 revenue miss, shares slip - Investing.com
Evogene earnings beat by $0.66, revenue fell short of estimates - Investing.com India
SEC Form 424B3 filed by Evogene Ltd - Quantisnow
Evogene (TSE:EVGN) Given New C$3.00 Price Target at Desjardins - Defense World
Evogene Ltd expected to post a loss of 72 cents a shareEarnings Preview - TradingView
Evogene (NASDAQ:EVGN) Now Covered by StockNews.com - Defense World
Evogene Ltd. to Host Earnings Call - ACCESS Newswire
Evogene (EVGN) Projected to Post Quarterly Earnings on Thursday - Defense World
Evogene Schedules Fourth Quarter 2024 Financial Results Release - Krishak Jagat English
Evogene Sets Date for Q4 Earnings: Key Details for Your Calendar - Stock Titan
AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease - Nasdaq
Revolutionary Discovery: New Weapon Against €1.2B Wheat Disease Threat Unveiled - Stock Titan
Evogene Shareholders Approve Key Proposal in Special Meeting - TipRanks
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - Armenian Reporter
Evogene Ltd. Reschedules Special General Meeting Due to Lack of Quorum - TipRanks
Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com - Defense World
United States Agricultural Biologicals Market Competition - GlobeNewswire
United States Agricultural Biologicals Market Competition and Forecasts 2024-2029, Competitive Analysis of BASF, Syngenta Crop Protection, Bayer, Evogene ,Vegalab Inc. - Yahoo Finance
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - GuruFocus.com
Monsanto Expands Agreement with Israel’s Evogene - Agribusiness Global
Higher R&D costs lead Evogene to loss - גלובס
Evogene Ltd. Announces Conclusion of Employment of Eyal Ronen as Executive Vice President of Business Development, Effective March 4, 2025 - Marketscreener.com
Evogene Announces Management Restructuring - TipRanks
Evogene Ltd Stock (EVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):